Volume, Dry Weight, & Intradialytic

The contract between this chapter and the reader.

1. 1. Explain volume as the core cardiovascular problem of haemodialysis.
2. 2. Define dry weight and assess it with clinical and objective tools.
3. 3. Relate interdialytic weight gain and sodium to the ultrafiltration requirement.
4. 4. Keep the ultrafiltration rate within a safe range.
5. 5. Explain the pathophysiology of intradialytic hypotension.
6. 6. Treat an acute episode of intradialytic hypotension.
7. 7. Prevent intradialytic hypotension.
8. 8. Manage hypertension from euvolemia first.
9. 9. Link chronic overload to left-ventricular hypertrophy and cardiovascular mortality.

A sixty-second reading. Each bullet stands alone.

• Volume is the core cardiovascular problem of HD: chronic overload causes hypertension, left-ventricular hypertrophy, and death, while rapid removal causes intradialytic hypotension and organ stunning.
• The task is to reach euvolemia without removing fluid faster than the body can tolerate.
• Dry weight is the lowest weight tolerated without hypotension or symptoms, at which the patient is normotensive without antihypertensives.
• Assess volume clinically — blood pressure, oedema, JVP, lung crackles — and, where available, with bioimpedance, lung ultrasound, and relative-blood-volume monitoring.
• Interdialytic weight gain, driven by salt-induced thirst, sets the ultrafiltration requirement.
• Dietary salt restriction is the cornerstone; keep dialysate sodium near plasma and avoid sodium loading.
• High ultrafiltration rates (beyond about 10–13 mL/kg/h) are linked to hypotension, myocardial stunning, and mortality.
• Lower the ultrafiltration rate with longer or more frequent sessions and less interdialytic gain — not by pulling harder.
• Intradialytic hypotension occurs when ultrafiltration outpaces plasma refilling, worsened by impaired vasoconstriction, cardiac dysfunction, eating, antihypertensives, and warm dialysate.
• Treat an acute episode by stopping ultrafiltration, laying the patient flat, and giving fluid — then reassess.
• Prevent it with cooler dialysate, a lower ultrafiltration rate, avoiding food during dialysis, holding pre-dialysis antihypertensives, and adequate dialysate calcium.
• Hypertension is mostly volume-dependent: achieve dry weight first, then add antihypertensives, allowing for a lag before blood pressure falls.
• Chronic overload drives left-ventricular hypertrophy, which partly regresses with euvolemia.

The medical core. An expert should agree volume and IDH are fully covered here.

Why it matters at the bedside

Volume is where haemodialysis does its most good and its most harm. Leave fluid on and the heart pays over months; pull it off too fast and the patient pays in the chair, with hypotension and stunned organs. The whole craft is reaching dry weight at a speed the body can survive.

Volume as the core cardiovascular problem

• Chronic fluid overload raises blood pressure and, with it, drives left-ventricular hypertrophy and the high cardiovascular mortality of dialysis. The opposite error — removing fluid faster than the circulation tolerates — causes intradialytic hypotension and repeated ischaemic injury. Both ends of the volume problem kill, which is why euvolemia, reached gently, is the central goal.

Dry weight and assessing it

• Dry weight is the lowest post-dialysis weight a patient tolerates without hypotension or cramps, at which they are normotensive without antihypertensives and free of overload. It resists precise definition, so it is judged from the clinical picture — blood pressure, oedema, jugular venous pressure, lung crackles — and, where available, bioimpedance, lung ultrasound, and relative-blood-volume monitoring. It is found by probing: lowering the target gradually and backing off at the first hypotension or cramp.

Interdialytic gain and sodium

• Between sessions the patient gains fluid in proportion to salt intake, because sodium drives thirst. That interdialytic weight gain sets how much must be removed and how fast — so the lever that matters most is dietary salt restriction, supported by keeping dialysate sodium near plasma and avoiding the sodium loading that worsens thirst and the next gain.

The ultrafiltration rate

• How fast fluid is removed is itself a risk. Ultrafiltration rates beyond roughly 10–13 mL/kg/h are linked to intradialytic hypotension, myocardial stunning, and mortality. When the rate is too high, the answer is to remove the same fluid over more time — longer or more frequent sessions — and to cut interdialytic gain, not to pull harder.

Intradialytic hypotension — pathophysiology

• Hypotension on dialysis happens when ultrafiltration removes plasma faster than the interstitium can refill it, draining the intravascular space. Several factors make it worse: impaired compensatory vasoconstriction and autonomic neuropathy, poor cardiac reserve, eating during the session (which pools blood in the gut), antihypertensives taken before dialysis, a warm dialysate, and a low dialysate calcium.

Treating acute IDH

• When the pressure drops mid-session, stop or reduce ultrafiltration, lay the patient flat (head-down), and give fluid — a saline bolus, or hypertonic saline or mannitol if needed. Then reassess: the episode is a signal to re-examine the dry weight, the ultrafiltration rate, and the contributing factors, not just to rescue and continue.

Preventing IDH

• Prevention is more valuable than rescue, because each episode injures organs. Cool the dialysate (around 35.5 °C), lower the ultrafiltration rate by lengthening or adding sessions, avoid food during dialysis, hold pre-dialysis antihypertensives, and ensure an adequate dialysate calcium. Refractory cases may need midodrine or isolated ultrafiltration.

Hypertension: euvolemia first

• Most hypertension in HD is volume-dependent, so the first move is to reach dry weight rather than to add drugs. Blood pressure often falls only days to weeks after the dry weight is lowered — the lag phenomenon — so the target is approached patiently and not over-corrected; interdialytic and ambulatory readings predict outcome better than the peridialytic numbers.

Volume and the heart

• The link runs both ways: chronic overload drives left-ventricular hypertrophy, much of which regresses once the patient is truly euvolemic, while repeated intradialytic hypotension stuns the myocardium and other organs, accumulating ischaemic injury over time. Treating volume well is, in the end, cardiac protection.

Evidence base

• The harm of high ultrafiltration rates and of chronic overload rests on consistent observational data; the benefit of cooler dialysate for intradialytic hypotension rests on randomised and observational trials; and the blood-pressure benefit of reaching dry weight rests on dry-weight-reduction studies.

Five fully-built tables.

Table A — Assessing volume

Table B — Causes of intradialytic hypotension

Table C — Treating acute IDH

Table D — Preventing IDH

Table E — Dry weight and sodium principles

Visualise & Map

Causal chains, each ending in a named action.

Chain 1 — Outpacing refill

High ultrafiltration rate → plasma removed faster than the interstitium refills → intravascular hypovolaemia → intradialytic hypotension → ACTION: lower the UF rate with more time, not more force.

Chain 2 — The salt cycle

High salt intake → thirst → large interdialytic weight gain → high ultrafiltration requirement → hypotension and overload → ACTION: restrict salt and keep dialysate sodium near plasma.

Chain 3 — Silent injury

Repeated intradialytic hypotension → myocardial, cerebral, and gut stunning → cumulative ischaemic injury → ACTION: prevent episodes with cool dialysate and a lower UF rate.

Chain 4 — Overload and the heart

Chronic overload → hypertension and left-ventricular hypertrophy → cardiovascular mortality → ACTION: reach dry weight (LVH partly regresses).

Chain 5 — Losing compensation

Warm dialysate, eating, and pre-dialysis antihypertensives → impaired vasoconstriction and splanchnic pooling → intradialytic hypotension → ACTION: cool the dialysate, avoid food, and hold pre-dialysis antihypertensives.

Numbered rules. These numbers are the cross-reference handle for the cases and flowcharts.

Clinical Reasoning

Five cases. Each stops you at a decision before it answers it.

Every mechanism from Level 3 earns a bedside consequence and an action.

Exhaustive. Every threshold and rule in the chapter is here.

Safety & Evidence

Panel A — Red flags

Panel B — NEVER DO

Anti-patterns clinicians fall into. Each becomes a Level 22 distractor.

The grade reflects strength of evidence, not importance.

Patient Decisions

Outcomes as natural frequencies. Figures are representative; the direction of effect is given where precise numbers are uncertain.

Apply & Test

Copy-paste chart notes that map to the real decisions in this chapter.

Template 1 — Volume / dry-weight assessment

• Clinical: BP ___; oedema ___; JVP ___; crackles ___.
• Objective: bioimpedance ___; lung ultrasound ___; relative blood volume ___.
• Interdialytic weight gain: ___; ultrafiltration rate: ___ mL/kg/h (within safe range? yes/no).
• Dry-weight plan: current ___; probing down to ___ gradually; lag expected.
• Salt restriction reinforced; dialysate sodium near plasma: yes/no.

Template 2 — Intradialytic hypotension plan

• Pattern: episodes per week ___; timing in session ___.
• Contributors: high UF rate / eating / pre-dialysis antihypertensives / warm dialysate / low Ca.
• Acute plan: stop UF, lay flat, fluid bolus.
• Preventive measures set: cool dialysate ___; lower UF rate ___; no food ___; hold antihypertensives ___.
• Refractory steps: dialysate calcium ___; midodrine ___; isolated UF ___.

Pre-rounds compression. Rules only.

Active recall. At least one card per objective.

Micro-teaching for rounds. Two scenarios, five steps each.

Metacognition anchored to this chapter's tensions. No answers provided.

1. 1. Reaching true dry weight means tolerating some hypotension while you probe; how do you balance that against the harm each episode does?
2. 2. Salt restriction is the most powerful lever and the one you least control between sessions; how do you make it real rather than a line in the notes?
3. 3. A high-sodium bath buys a calm session and a heavier week; how often do you trade the visible problem for the invisible one?
4. 4. The lag phenomenon asks for patience when the blood pressure won't move; what makes waiting harder than acting, and how do you hold the line?
5. 5. Intradialytic hypotension is treated and forgotten by the next session, yet its injury accumulates; how do you keep a silent, cumulative harm visible?

Nine items, each anchored in this chapter. At least one per objective.